“Long Xing Tian Xia” program took Humanwell Puracap as one example of many pharmaceutical companies who are exploiting oversea markets and learning their efforts on talents allocation and international standards compliance in order to enter highest threshold of global pharmaceutical market.

Guo Dahai, the CEO of Humanwell Puracap mentioned that there are 5,500 pharmaceutical companies in China and only 1%~2% of them are willing to export their products to European and United States markets, and only 20 pharmaceutical companies are qualified by FDA. Therefore, only four or five companies can open European and United States pharmaceutical business and Humanwell Puracap is one of the top two.